NRX Pharmaceuticals, Inc. Public Float
NRX Pharmaceuticals, Inc. (NRXP) had Public Float of $57.40 million as of 2025-06-30, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-23
- 2025-06-30: Entity Public Float $57.40M.
- 2024-06-30: Entity Public Float $21.50M.
- 2023-06-30: Entity Public Float $29.70M.
- 2022-12-31: Entity Public Float $34.95T.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $57.40M 10-K · filed 2026-03-23 |
| 2024-06-30 | $21.50M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $29.70M 10-K/A · filed 2024-04-29 |
| 2022-12-31 | $34.95T 10-K · filed 2023-03-31 |
| 2022-06-30 | $40.58T 10-K/A · filed 2023-05-26 |
| 2021-06-30 | $187.30M 10-K/A · filed 2022-04-29 |
| 2020-06-30 | $6.10M 10-K/A · filed 2021-05-14 |
| 2019-06-30 | $50.30M 10-K · filed 2020-03-30 |
| 2018-06-30 | $69.75M 10-K · filed 2019-03-15 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |